Funding

#Biotherapeutics #Funding #Probiotics #Start-ups

Start-up raises £1.3M to ‘revolutionise’ infant gut health

A female-led start-up developing a live biotherapeutic product to address infant gut needs, has raised £1.3M ($1.5M) in equity and grant funding.  BoobyBiome, founded by scientists Dr Lydia Mapstone, Dr Sioned Jones and Tara O’Driscoll, aims to develop a novel product for babies who do not have access to the… Read More

#Business & Investment #News #Start-up Zone

#Drug discovery #EMA #Funding #Huntington's disease #Monkeypox #Start-ups

This week in drug discovery (21 – 25 August)

News round-up for 21-25 August by DDW Editor Reece Armstrong A treatment for Monkeypox, spider venom for drug discovery and funding for international start-ups are some of the stories in this week’s news round-up. Covid researchers launch Monkeypox study   A new study investigating a potential treatment… Read More

#News

AI
#AI #Funding #Pharmaceutical

AI platform for pharma raises €12.1 million  

Technology company PeakData has raised €12.1 million in Series A funding to support its artificial intelligence (AI) platform.  Launched in 2018, PeakData enables pharmaceutical companies to uncover the whole therapeutic area by mapping the healthcare professionals (HCPs) most relevant to their target market. It’s hoped that this… Read More

#News

#AI #Chronic pain #Finance #Funding #Start-ups #Stem cells

International start-ups receive funding from BioInnovation 

Three international life sciences start-ups have received investment from the BioInnovation Institute (BII).   The three new ventures were chosen as part of the BII’s focus on developing scientific initiatives across the therapeutics and health tech space.  The companies, Sevenless Therapeutics, VEIL.AI and Myopax, will receive €1.3 million and will form… Read More

#Business & Investment #News

#Drug screening #Funding #Innovate UK #Microfluidics

Orbit Discovery awarded grant to advance screening platform  

Biopharmaceutical company Orbit Discovery has been awarded almost £500,000 in a grant to help it expand its microfluidics screening capabilities.   The £472,000 Smart grant was awarded by Innovate UK and will facilitate the implementation of droplet-based microfluidics for cell-based functional screening and expand the capabilities and throughput… Read More

#News

#Covid-19 #Funding

This week in drug discovery (28 March – 1 April) 

News round-up by DDW’s Megan Thomas for 28 March – 1 April, 2022  From Covid updates to life-saving investments, this week’s news shows how valuable the drug discovery industry is and the impact it makes.  1. Covid-19 approval milestone for those who can’t be… Read More

#News

#Funding #Investment

New biopharma deals report reveals spending trends 

Clarivate has released its annual Biopharma Deals Report, which highlights emerging market trends and features detailed analysis of the key deals of 2021 and potential implications for 2022, the full extent of which can be found on clarivate.com.  This year’s report finds US biotech companies raised the majority of capital… Read More

#News #Trends & Analysis

#Drug development #Drug innovation #Funding #Investment

CatSci secures £4.5 million funding deal for drug development 

CatSci, a partner for medicines development, has secured £4.5 million of investment to expedite the development and launch of what it calls its life-changing therapeutics.  The company develops economically and environmentally sustainable drug manufacturing processes that enable its global pharmaceutical customers to create affordable small molecule therapeutics… Read More

#News

#Funding #Immunotherapy #Rare disease

Ilya Pharma closes €8.5 million to advance its clinical programmes 

Ilya Pharma, a clinical stage immunotherapy company, has closed a €8.5 million funding round, which will be used to advance the company’s portfolio of three first-in-class immunotherapies for skin and mucosal diseases.   The portfolio   The active portfolio includes ILP100-Topical for treatment surgical wounds in diabetic,… Read More

#News

#Biopharmaceuticals #Drug development #Drug innovation #Funding

Key take-aways from new R&D trends report 

As the global Covid-19 pandemic enters its third year, the life sciences innovation system is setting new records in the level of investment, activity, and scientific progress, according to the IQVIA Institute. In its report, Global Trends in R&D: Overview through 2021, the IQVIA assesses the trends in new drug… Read More

#News #Trends & Analysis

#Animal testing #Awards #Funding #Innovation

Push continues to reduce reliance on animal research methods 

FRAME, a medical research charity that aims to reduce the number of animals used in scientific testing, has awarded a total of £29,000 to three projects with the potential to replace animal use in biomedical research.  The award  FRAME’s innovation grant funding stream is designed… Read More

#News

#Collaboration #Funding #Investment

CellCentric secures investment to advance targeted cancer therapy 

CellCentric has received funding from BrightEdge to further progress the clinical development of its targeted treatment, inobrodib (formerly known as CCS1477) and are accompanied by additional investment from existing lead investor, Morningside Investments Limited.  What is inobrodib?  Inobrodib is a first-in-class small molecule inhibitor that impacts twin regulatory proteins p300… Read More

#News

#Collaboration #Drug delivery #Funding #Research

12 new grants for infectious disease and antimicrobial resistance 

The Bloomsbury SET – a knowledge exchange programme led by the UK’s Royal Veterinary College (RVC) – has announced a Commercialisation Pilot of 12 new grants for projects which will develop tools to better fight infectious disease or antimicrobial resistance (AMR). Supported by more than £1 million of funding, these projects will bring together researchers and businesses… Read More

#News

#Drug discovery #Funding #Healthcare #Investment #Life sciences #Public health

Drug discovery investors: Who’s spending? 

While the research, results and trials often take centre-stage when it comes to drug discovery and development reporting, DDW’s Megan Thomas spotlights the funding and investments which make this possible.   1. US researcher awarded $3.6 million to study antibiotic resistance  Sanford Burnham Prebys professor Andrei Osterman, Ph.D., has been awarded a $3.6 million… Read More

#Business & Investment #Editor's Choice #Exclusive Content #News

#Biomarkers #Biopharmaceuticals #Biotechnology #Funding

€13.5m financing round to accelerate proteomics tools and consumables 

PreOmics has raised €13.5 million in a Series B financing round provided by Bruker Corporation, which is expected to broaden the market opportunities for both PreOmics’ platform technologies and Bruker’s  proteomics platform with more complete, automated workflow solutions for academic and clinical researchers, for biomarker discovery and diagnostics companies, as well as for… Read More

#News

#Cell and gene therapy #Funding

Ori Biotech raises over $100 million to launch CGT platform 

Ori Biotech, a producer of cell and gene therapy (CGT) manufacturing technology, has secured over $100 million in an oversubscribed Series B funding round and will use the funds to further expand key personnel across all functions, in order to rapidly transition through pre-commercialisation to the launch of its CGT manufacturing platform. … Read More

#News